As of 31 Dec 2025, 0 institutional investors reported holding shares of TEVA PHARMACEUTICAL INDS LTD - CALL.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $31.21 | 0 | |||
| 2025 Q3 | $20.20 | 0 | |||
| 2025 Q2 | $16.76 | 0 | |||
| 2025 Q1 | $15.37 | 0 | |||
| 2024 Q4 | $22.04 | 0 | |||
| 2024 Q3 | $18.02 | 0 | |||
| 2024 Q2 | 0 | $0 | -$20,953,000 | $16.25 | 0 |
| 2024 Q1 | 1,485,000 | $20,953,000 | -$7,324,673 | $14.11 | 1 |
| 2023 Q4 | 701,597 | $7,324,673 | $10.44 | 1 | |
| 2023 Q3 | $10.20 | 0 | |||
| 2023 Q2 | $7.53 | 0 | |||
| 2023 Q1 | $8.85 | 0 | |||
| 2022 Q4 | $9.12 | 0 | |||
| 2022 Q3 | $8.07 | 0 | |||
| 2022 Q2 | $7.52 | 0 | |||
| 2022 Q1 | $9.39 | 0 | |||
| 2021 Q4 | $8.01 | 0 | |||
| 2021 Q3 | $9.74 | 0 | |||
| 2021 Q2 | $9.90 | 0 | |||
| 2021 Q1 | $11.54 | 0 | |||
| 2020 Q4 | $9.65 | 0 | |||
| 2020 Q3 | $9.01 | 0 | |||
| 2020 Q2 | $12.33 | 0 | |||
| 2020 Q1 | $8.98 | 0 | |||
| 2019 Q4 | $9.80 | 0 | |||
| 2019 Q3 | $6.88 | 0 | |||
| 2019 Q2 | $9.23 | 0 | |||
| 2019 Q1 | $15.68 | 0 | |||
| 2018 Q4 | $15.42 | 0 | |||
| 2018 Q3 | $360.77 | 0 | |||
| 2018 Q2 | $24.32 | 0 | |||
| 2018 Q1 | $17.09 | 0 | |||
| 2017 Q4 | 0 | $0 | -$403,000 | $18.95 | 0 |
| 2017 Q3 | 11,500 | $403,000 | -$1,072,330 | $35.04 | 1 |
| 2017 Q2 | 42,100 | $1,605,000 | -$105,000 | $35.67 | 1 |
| 2017 Q1 | 757 | $105,000 | +$105,000 | $32.09 | 1 |
| 2016 Q4 | 8,600 | $346,000 | +$346,000 | $36.25 | 1 |
| 2016 Q3 | $46.00 | 0 | |||
| 2016 Q2 | $50.23 | 0 | |||
| 2016 Q1 | $53.51 | 0 | |||
| 2015 Q4 | 0 | $0 | -$641,000 | $65.64 | 0 |
| 2015 Q3 | 150,800 | $641,000 | +$641,000 | $56.46 | 1 |
| 2015 Q2 | $59.10 | 0 | |||
| 2015 Q1 | $62.31 | 0 | |||
| 2014 Q4 | $57.51 | 0 | |||
| 2014 Q3 | $53.75 | 0 | |||
| 2014 Q2 | $219.36 | 0 | |||
| 2014 Q1 | $52.84 | 0 |